The U.S. Food and Drug Administration (FDA) has given 510(k) clearance to Stockholm-based RaySearch Laboratories and Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium, for their jointly developed Compass dosimetry device.
Compass is designed to enable medical staff to measure and reconstruct in 3D the radiation dose that was delivered to a patient during the course of treatment.
Related Reading
IBA sells cyclotron to Saudi Arabia, December 4, 2007
IBA, PETLinQ acquire SourceMedical's radiology division, November 26, 2007
IBA to acquire full interest in CIS Bio, September 14, 2007
IBA buries proton hatchet with Optivus, Loma Linda, August 21, 2007
IBA to equip fourth U.S. proton therapy center, July 25, 2007
Copyright © 2007 AuntMinnie.com